DouglasASimonettoMD(He/Him)

Hepatology & Liver Transplantation

Associate Professor of Medicine

Dr. Simonetto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Transplant Hepatology, 2015 - 2016
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2012 - 2015
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2009 - 2012
Hlth Scis Fed Univ Porto AlegreClass of 2007

PubMed

Forecasting Alcohol-Related Liver Disease Mortality Trends in Younger Populations Using Advanced Time-Series Models: A 1999-2030 Analysis.
Hassam Ali, Vinay Jahagirdar, Hanna Blaney, Dushyant Singh Dahiya, Manesh K Gangwani
JGH Open. 2024-12-01
1 citations
Pulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders.
Kelly M Pennington, Douglas Simonetto, Timucin Taner, Abhishek A Mangaonkar
Current Hematologic Malignancy Reports. 2024-12-01
Liver transplantation for alcohol-associated liver disease.
Douglas A Simonetto, Gerald Scott Winder, Ashton A Connor, Norah A Terrault
Hepatology. 2024-12-01

Journal Articles

Comparison of Therapies for Primary Prevention of Esophageal Variceal Bleeding: A Systematic Review and Network Meta‐Analysis
Douglas A Simonetto, Mohammad Hassan Murad, Siddharth Singh, Patrick S Kamath, Hepatology

Abstracts/Posters

Clinical Utility of Telomere Length-Directed Genomic Assessment in Patients with Short Telomere Syndromes
Douglas A Simonetto, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

PharmaIN Unveils Interim Phase 1b Clinical Data on the Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - the Liver Meeting® 2024November 18th, 2024
PharmaIN to Present Promising Interim Data from Its Ongoing Phase 1 Trial of PHIN-214, an Optimized Vasopressor for Decompensated Cirrhosis, at the Liver Meeting® 2024October 16th, 2024
Surge in Alcohol-Related Disease During Pandemic Reveals Unmet Need for TreatmentMay 31st, 2022
Join now to see all